Emmessar Biotech & Nutrition Limited (BOM:524768)
28.07
-0.47 (-1.65%)
At close: Jan 20, 2026
BOM:524768 Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 71.95 | 0.11 | 0.13 | 0.12 | 1.82 | 24.71 | Upgrade |
Short-Term Investments | 0.1 | 77.71 | 61.79 | 51.89 | 44.1 | 0.08 | Upgrade |
Cash & Short-Term Investments | 72.05 | 77.81 | 61.92 | 52 | 45.92 | 24.78 | Upgrade |
Cash Growth | 8.28% | 25.68% | 19.06% | 13.25% | 85.27% | 31.25% | Upgrade |
Accounts Receivable | 0.18 | 0.18 | 0.22 | 0.11 | 0.13 | 27.1 | Upgrade |
Other Receivables | - | - | - | 0.9 | 1.14 | - | Upgrade |
Receivables | 0.47 | 0.48 | 0.36 | 1.1 | 1.33 | 27.11 | Upgrade |
Inventory | 1.11 | 1.24 | 0.89 | 1.36 | 0.68 | 0.67 | Upgrade |
Prepaid Expenses | 0.95 | 0.93 | 0.96 | 0.67 | 0.55 | - | Upgrade |
Other Current Assets | 2.86 | -6.4 | 4.19 | 4.21 | 0.14 | 1.38 | Upgrade |
Total Current Assets | 77.44 | 74.06 | 68.32 | 59.34 | 48.61 | 53.94 | Upgrade |
Property, Plant & Equipment | 11.84 | 12.21 | 13.09 | 13.97 | 14.55 | 12.33 | Upgrade |
Long-Term Deferred Tax Assets | - | - | - | - | 2.78 | 5.41 | Upgrade |
Other Long-Term Assets | 5.88 | 5.93 | 6.02 | 6.12 | 6.19 | 6.38 | Upgrade |
Total Assets | 95.16 | 92.2 | 87.43 | 79.43 | 72.14 | 78.07 | Upgrade |
Accounts Payable | 0.02 | 0.03 | 0.09 | - | 0.22 | 4.96 | Upgrade |
Accrued Expenses | 3.28 | 1.8 | 3.85 | 3.38 | 2.99 | - | Upgrade |
Short-Term Debt | - | - | 1.09 | 0.82 | - | - | Upgrade |
Current Income Taxes Payable | 0.71 | 2.73 | - | - | - | 2.44 | Upgrade |
Other Current Liabilities | 0.83 | 0.17 | - | -0 | 0.09 | 6.63 | Upgrade |
Total Current Liabilities | 4.83 | 4.73 | 5.04 | 4.2 | 3.3 | 14.02 | Upgrade |
Pension & Post-Retirement Benefits | 1.31 | 1.31 | 1.09 | 1.12 | 1 | - | Upgrade |
Long-Term Deferred Tax Liabilities | 3.06 | 3.15 | 1.13 | 1.32 | - | - | Upgrade |
Other Long-Term Liabilities | 6.04 | 5.94 | 6.14 | 6.14 | 6.14 | 7.03 | Upgrade |
Total Liabilities | 15.23 | 15.12 | 13.41 | 12.78 | 10.45 | 21.06 | Upgrade |
Common Stock | 49.96 | 49.96 | 49.96 | 49.96 | 49.96 | 49.96 | Upgrade |
Retained Earnings | - | 27.96 | 24.8 | 17.31 | 12.27 | - | Upgrade |
Comprehensive Income & Other | 29.97 | -0.84 | -0.74 | -0.62 | -0.54 | 7.05 | Upgrade |
Shareholders' Equity | 79.93 | 77.08 | 74.02 | 66.65 | 61.69 | 57.01 | Upgrade |
Total Liabilities & Equity | 95.16 | 92.2 | 87.43 | 79.43 | 72.14 | 78.07 | Upgrade |
Total Debt | - | - | 1.09 | 0.82 | - | - | Upgrade |
Net Cash (Debt) | 72.05 | 77.81 | 60.82 | 51.18 | 45.92 | 24.78 | Upgrade |
Net Cash Growth | 8.28% | 27.94% | 18.83% | 11.46% | 85.27% | 31.25% | Upgrade |
Net Cash Per Share | 14.37 | 15.58 | 12.17 | 10.24 | 9.19 | 4.96 | Upgrade |
Filing Date Shares Outstanding | 4.96 | 5 | 5 | 5 | 5 | 5 | Upgrade |
Total Common Shares Outstanding | 4.96 | 5 | 5 | 5 | 5 | 5 | Upgrade |
Working Capital | 72.61 | 69.34 | 63.28 | 55.14 | 45.31 | 39.92 | Upgrade |
Book Value Per Share | 16.13 | 15.43 | 14.82 | 13.34 | 12.35 | 11.41 | Upgrade |
Tangible Book Value | 79.93 | 77.08 | 74.02 | 66.65 | 61.69 | 57.01 | Upgrade |
Tangible Book Value Per Share | 16.13 | 15.43 | 14.82 | 13.34 | 12.35 | 11.41 | Upgrade |
Buildings | - | 15.4 | 15.4 | 15.4 | 15.4 | 15.4 | Upgrade |
Machinery | - | 5.04 | 5.04 | 5.04 | 4.78 | 1.72 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.